{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:23:46Z","timestamp":1773285826887,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000145","name":"Alberta Innovates Health Sciences (AIHS)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000145","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science and Engineering Research Council of Canada (NSERC)"},{"name":"U. of Alberta (MOST)"},{"name":"NSERC CREATE Program"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jconrel.2013.05.014","type":"journal-article","created":{"date-parts":[[2013,5,28]],"date-time":"2013-05-28T02:03:46Z","timestamp":1369706626000},"page":"495-503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Investigating siRNA delivery to chronic myeloid leukemia K562 cells with lipophilic polymers for therapeutic BCR-ABL down-regulation"],"prefix":"10.1016","volume":"172","author":[{"given":"Juliana","family":"Valencia-Serna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilal","family":"Gul-Uluda\u011f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parvin","family":"Mahdipoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Uluda\u011f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2013.05.014_bb0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(05)17945-8","article-title":"Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial","volume":"365","author":"Bocchia","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2013.05.014_bb0010","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1038\/onc.2009.107","article-title":"Kinase drug discovery approaches in chronic myeloproliferative disorders","volume":"28","author":"Kumar","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2013.05.014_bb0015","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/leu.2010.159","article-title":"Insights into the stem cells of chronic myeloid leukemia","volume":"24","author":"Sloma","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2013.05.014_bb0020","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra020777","article-title":"Chronic myeloid leukemia \u2013 advances in biology and new approaches to treatment \u2013 NEJM","volume":"349","author":"Goldman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0025","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","article-title":"Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet","volume":"27","author":"Baccarani","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11899-012-0119-0","article-title":"Genomic instability in chronic myeloid leukemia: targets for therapy?","volume":"7","author":"Muvarak","year":"2012","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0035","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.3109\/10428194.2010.507830","article-title":"Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells","volume":"51","author":"Kosova","year":"2010","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.jconrel.2013.05.014_bb0040","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.leukres.2011.04.005","article-title":"Inhibition of PRAME expression causes cell cycle arrest and apoptosis in leukemic cells","volume":"35","author":"Tanaka","year":"2011","journal-title":"Leuk. Res."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0045","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/cmdc.200700329","article-title":"Targeted RNA interference of cyclin\u2005A2 mediated by functionalized single-walled carbon nanotubes induces proliferation arrest and apoptosis in chronic myelogenous leukemia K562 cells","volume":"3","author":"Wang","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jconrel.2013.05.014_bb0050","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1038\/sj.onc.1205653","article-title":"Killing of leukemic cells with a BCR\/ABL fusion gene by RNA interference (RNAi)","volume":"21","author":"Wilda","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2013.05.014_bb0055","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1242\/jcs.066399","article-title":"Breaking down the barriers: siRNA delivery and endosome escape","volume":"123","author":"Dominska","year":"2010","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0060","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1021\/cr800409e","article-title":"Nonviral vectors for gene delivery","volume":"109","author":"Mintzer","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0065","series-title":"Intracellular Delivery: Fundamentals and Applications","author":"Prokop","year":"2011"},{"key":"10.1016\/j.jconrel.2013.05.014_bb0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11033-006-9006-x","article-title":"Targeting of gene expression by siRNA in CML primary cells","volume":"34","author":"Merkerova","year":"2007","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/sj.leu.2403999","article-title":"Transient or long-term silencing of BCR-ABL alone induces cell cycle and proliferation arrest, apoptosis and differentiation","volume":"20","author":"Rangatia","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2013.05.014_bb0080","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jconrel.2010.04.011","article-title":"Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting BCR-ABL fusion gene in chronic myeloid leukemia cells","volume":"145","author":"Arthanari","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.05.014_bb0085","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1261\/rna.459807","article-title":"Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting","volume":"13","author":"De Paula","year":"2007","journal-title":"RNA"},{"key":"10.1016\/j.jconrel.2013.05.014_bb0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: advances in siRNA delivery","volume":"8","author":"Whitehead","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0095","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1021\/mp900074d","article-title":"Aliphatic lipid substitution on 2kDa polyethylenimine improves plasmid delivery and transgene expression","volume":"6","author":"Neamnark","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0100","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/mabi.201000402","article-title":"Impact of lipid substitution on assembly and delivery of siRNA by cationic polymers","volume":"11","author":"Aliabadi","year":"2011","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0105","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.actbio.2011.01.027","article-title":"Lipid substitution on low molecular weight (0.6\u20132.0kDa) polyethylenimine leads to a higher zeta potential of plasmid DNA and enhances transgene expression","volume":"7","author":"Remant Bahadur","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0110","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ijc.2910180405","article-title":"Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia","volume":"18","author":"Klein","year":"1976","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2013.05.014_bb0115","first-page":"2657","article-title":"AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem\/progenitor cells","volume":"205","author":"Zhou","year":"2008","journal-title":"CORD Conference Proceedings"},{"key":"10.1016\/j.jconrel.2013.05.014_bb0120","doi-asserted-by":"crossref","first-page":"e44197","DOI":"10.1371\/journal.pone.0044197","article-title":"Effective non-viral delivery of siRNA to acute myeloid leukemia cells with lipid-substituted polyethylenimines","volume":"7","author":"Landry","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jconrel.2013.05.014_bb0125","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/term.532","article-title":"Effect of basic fibroblast growth factor in mouse embryonic stem cell culture and osteogenic differentiation","volume":"7","author":"Rose","year":"2012","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0130","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1021\/bm800132n","article-title":"Further investigation of lipid-substituted poly(l-Lysine) polymers for transfection of human skin fibroblasts","volume":"9","author":"Abbasi","year":"2008","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2013.05.014_bb0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1021\/mp8000815","article-title":"Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine","volume":"6","author":"Alshamsan","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0140","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ejpb.2006.11.026","article-title":"A comparison of the effectiveness of cationic polymers poly-l-lysine (PLL) and polyethylenimine (PEI) for non-viral delivery of plasmid DNA to bone marrow stromal cells (BMSC)","volume":"65","author":"Farrell","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0145","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1021\/mp200176v","article-title":"Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell line","volume":"8","author":"Aliabadi","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0150","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.gt.3300896","article-title":"Transgene expression, but not gene delivery, is improved by adhesion-assisted lipofection of hematopoietic cells","volume":"6","author":"Keller","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0155","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.exphem.2011.08.003","article-title":"Nonviral transfection of leukemic primary cells and cells lines by siRNA \u2014 a direct comparison between Nucleofection and Accell delivery","volume":"39","author":"Larsen","year":"2011","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-0556-2-1","article-title":"Novel non-viral method for transfection of primary leukemia cells and cell lines","volume":"2","author":"Schakowski","year":"2004","journal-title":"Genet.Vaccines Ther."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0165","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood.V98.1.49","article-title":"Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells","volume":"98","author":"Van Tendeloo","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2013.05.014_bb0170","first-page":"1010","article-title":"An electron microscopy study into the mechanism of gene transfer with lipopolyamines","volume":"3","author":"Labat-Moleur","year":"1996","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0175","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nprot.2012.038","article-title":"A simple and rapid nonviral approach to efficiently transfect primary tissue-derived cells using polyethylenimine","volume":"7","author":"Hsu","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0180","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jconrel.2011.05.001","article-title":"How to screen non-viral gene delivery systems in vitro?","volume":"154","author":"van Gaal","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.05.014_bb0185","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jgm.1526","article-title":"Improved transfection efficiency of an aliphatic lipid substituted 2kDa polyethylenimine is attributed to enhanced nuclear association and uptake in rat bone marrow stromal cell","volume":"13","author":"Hsu","year":"2010","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0190","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1016\/j.biomaterials.2012.01.031","article-title":"Protein expression following non-viral delivery of plasmid DNA coding for basic FGF and BMP-2 in a rat ectopic model","volume":"33","author":"Rose","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2013.05.014_bb0195","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/j.1582-4934.2010.01130.x","article-title":"Polyethylenimine-mediated gene delivery into human bone marrow mesenchymal stem cells from patients","volume":"15","author":"Wang","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0200","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ymthe.2004.12.006","article-title":"Formation and intracellular trafficking of lipoplexes and polyplexes","volume":"11","author":"Elouahabi","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0205","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1039\/b916362j","article-title":"Lipid and hydrophobic modification of cationic carriers on route to superior gene vectors","volume":"6","author":"Incani","year":"2010","journal-title":"Soft Matter"},{"key":"10.1016\/j.jconrel.2013.05.014_bb0210","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2141.2005.05468.x","article-title":"Targeting primary human leukaemia cells with RNA interference: Bcr-Abl targeting inhibits myeloid progenitor self-renewal in chronic myeloid leukaemia cells","volume":"129","author":"Withey","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jconrel.2013.05.014_bb0215","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.febslet.2004.06.048","article-title":"Suppression of bcr-abl synthesis by siRNAs or tyrosine kinase activity by Glivec alters different oncogenes, apoptotic\/antiapoptotic genes and cell proliferation factors (microarray study)","volume":"570","author":"Zhelev","year":"2004","journal-title":"FEBS Lett."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913003040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913003040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:29:08Z","timestamp":1759159748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365913003040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0168365913003040"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.05.014","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating siRNA delivery to chronic myeloid leukemia K562 cells with lipophilic polymers for therapeutic BCR-ABL down-regulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}